TENAX THERAPEUTICS, INC.: 10-Q filed 2014-12-15
What TENAX THERAPEUTICS, INC. reported in its quarterly report filed 2014-12-15 (fiscal Q2 2015): 43 published measures, 122 facts as tagged in accession 0001354488-14-006182.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2014-12-15
- Fiscal period
- fiscal Q2 2015
- Accession
- 0001354488-14-006182 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All TENAX THERAPEUTICS, INC. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-10-31 | 89,222,264 | USD | |
| At 2014-04-30 | 93,429,440 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-10-31 | 11,635,437 | USD | |
| At 2014-04-30 | 10,544,079 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-10-31 | 77,586,827 | USD | |
| At 2014-04-30 | 82,885,361 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-10-31 | 14,356,140 | USD | |
| At 2014-04-30 | 58,320,555 | USD | |
| At 2013-10-31 | 2,542,942 | USD | |
| At 2013-04-30 | 783,528 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-08-01 to 2014-10-31 | -4,054,963 | USD | 92 |
| 2014-05-01 to 2014-10-31 | -6,226,375 | USD | 184 |
| 2013-08-01 to 2013-10-31 | -3,531,486 | USD | 92 |
| 2013-05-01 to 2013-10-31 | -5,776,759 | USD | 184 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-05-01 to 2014-10-31 | -4,894,825 | USD | 184 |
| 2013-05-01 to 2013-10-31 | -3,576,368 | USD | 184 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-05-01 to 2014-10-31 | 41,655,184 | USD | 184 |
| 2013-05-01 to 2013-10-31 | 0 | USD | 184 |
Revenue
Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-08-01 to 2014-10-31 | 0 | USD | 92 |
| 2014-05-01 to 2014-10-31 | 0 | USD | 184 |
| 2013-08-01 to 2013-10-31 | 55,707 | USD | 92 |
| 2013-05-01 to 2013-10-31 | 221,512 | USD | 184 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-05-01 to 2014-10-31 | 180,429 | USD | 184 |
| 2013-05-01 to 2013-10-31 | 5,404,649 | USD | 184 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-05-01 to 2014-10-31 | -39,250,019 | USD | 184 |
| 2013-05-01 to 2013-10-31 | -68,867 | USD | 184 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-10-31 | -142,812,298 | USD | |
| At 2014-04-30 | -136,585,923 | USD |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-08-01 to 2014-10-31 | 28,107,395 | shares | 92 |
| 2014-05-01 to 2014-10-31 | 28,037,204 | shares | 184 |
| 2013-08-01 to 2013-10-31 | 4,942,362 | shares | 92 |
| 2013-05-01 to 2013-10-31 | 3,549,698 | shares | 184 |
Diluted weighted-average shares
Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-08-01 to 2014-10-31 | 28,107,395 | shares | 92 |
| 2014-05-01 to 2014-10-31 | 28,037,204 | shares | 184 |
| 2013-08-01 to 2013-10-31 | 4,948,942 | shares | 92 |
| 2013-05-01 to 2013-10-31 | 3,556,357 | shares | 184 |
Basic earnings per share
Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-08-01 to 2014-10-31 | -0.14 | USD/shares | 92 |
| 2014-05-01 to 2014-10-31 | -0.22 | USD/shares | 184 |
| 2013-08-01 to 2013-10-31 | -1.23 | USD/shares | 92 |
| 2013-05-01 to 2013-10-31 | -2.94 | USD/shares | 184 |
Diluted earnings per share
Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-08-01 to 2014-10-31 | -0.14 | USD/shares | 92 |
| 2014-05-01 to 2014-10-31 | -0.22 | USD/shares | 184 |
| 2013-08-01 to 2013-10-31 | -1.25 | USD/shares | 92 |
| 2013-05-01 to 2013-10-31 | -2.96 | USD/shares | 184 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-10-31 | 81,646 | USD | |
| At 2014-04-30 | 124,374 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-05-01 to 2014-10-31 | 49,708 | USD | 184 |
| 2013-05-01 to 2013-10-31 | 80,177 | USD | 184 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-08-01 to 2014-10-31 | -4,143,195 | USD | 92 |
| 2014-05-01 to 2014-10-31 | -6,559,567 | USD | 184 |
| 2013-08-01 to 2013-10-31 | -2,114,263 | USD | 92 |
| 2013-05-01 to 2013-10-31 | -3,703,872 | USD | 184 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-10-31 | 23,007,680 | USD | |
| At 2014-04-30 | 58,966,033 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-08-01 to 2014-10-31 | 59 | USD | 92 |
| 2014-05-01 to 2014-10-31 | 46,320 | USD | 184 |
| 2013-08-01 to 2013-10-31 | 1,416,856 | USD | 92 |
| 2013-05-01 to 2013-10-31 | 2,072,660 | USD | 184 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-10-31 | 3,673,337 | USD | |
| At 2014-04-30 | 2,571,047 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-10-31 | 1,652,481 | USD | |
| At 2014-04-30 | 411,145 | USD |
Goodwill carrying amount
Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-10-31 | 11,265,100 | USD | |
| At 2014-04-30 | 11,265,100 | USD |
Net finite-lived intangible assets
Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-10-31 | 23,030,255 | USD | |
| At 2014-04-30 | 22,999,744 | USD |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-10-31 | 36,358 | USD | |
| At 2014-04-30 | 36,358 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-08-01 to 2014-10-31 | 4,143,195 | USD | 92 |
| 2014-05-01 to 2014-10-31 | 6,559,567 | USD | 184 |
| 2013-08-01 to 2013-10-31 | 2,169,970 | USD | 92 |
| 2013-05-01 to 2013-10-31 | 3,925,384 | USD | 184 |
Gross profit
Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-08-01 to 2014-10-31 | 0 | USD | 92 |
| 2014-05-01 to 2014-10-31 | 0 | USD | 184 |
| 2013-08-01 to 2013-10-31 | 21,330 | USD | 92 |
| 2013-05-01 to 2013-10-31 | 29,215 | USD | 184 |
Selling, general and administrative expense
Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-08-01 to 2014-10-31 | 1,586,343 | USD | 92 |
| 2014-05-01 to 2014-10-31 | 3,036,202 | USD | 184 |
| 2013-08-01 to 2013-10-31 | 1,421,405 | USD | 92 |
| 2013-05-01 to 2013-10-31 | 2,403,926 | USD | 184 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-08-01 to 2014-10-31 | 2,556,852 | USD | 92 |
| 2014-05-01 to 2014-10-31 | 3,523,365 | USD | 184 |
| 2013-08-01 to 2013-10-31 | 748,565 | USD | 92 |
| 2013-05-01 to 2013-10-31 | 1,521,458 | USD | 184 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-10-31 | 28,119,359 | shares | |
| At 2014-04-30 | 27,858,000 | shares |
Accumulated other comprehensive income or loss
Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-10-31 | -42,306 | USD | |
| At 2014-04-30 | 0 | USD |
Gross property, plant and equipment
Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-10-31 | 956,204 | USD | |
| At 2014-04-30 | 956,204 | USD |
Accumulated depreciation on property, plant and equipment
Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-10-31 | -874,558 | USD | |
| At 2014-04-30 | -831,830 | USD |
Net intangible assets excluding goodwill
Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-10-31 | 23,030,255 | USD | |
| At 2014-04-30 | 22,999,744 | USD |
Other noncurrent assets
Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-10-31 | 1,156,785 | USD | |
| At 2014-04-30 | 52,762 | USD |
Other noncurrent liabilities
Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-10-31 | 0 | USD | |
| At 2014-04-30 | 10,932 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-10-31 | 1,304,097 | USD | |
| At 2014-04-30 | 858,136 | USD |
Comprehensive income or loss
Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-08-01 to 2014-10-31 | 4,031,709 | USD | 92 |
| 2014-05-01 to 2014-10-31 | 6,268,681 | USD | 184 |
| 2013-08-01 to 2013-10-31 | 3,531,486 | USD | 92 |
| 2013-05-01 to 2013-10-31 | 5,776,759 | USD | 184 |
Net income available to common stockholders
Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-08-01 to 2014-10-31 | 4,054,963 | USD | 92 |
| 2014-05-01 to 2014-10-31 | 6,226,375 | USD | 184 |
| 2013-08-01 to 2013-10-31 | 6,083,275 | USD | 92 |
| 2013-05-01 to 2013-10-31 | 10,422,099 | USD | 184 |
Depreciation expense
Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-08-01 to 2014-10-31 | 21,000 | USD | 92 |
| 2014-05-01 to 2014-10-31 | 43,000 | USD | 184 |
| 2013-08-01 to 2013-10-31 | 23,000 | USD | 92 |
| 2013-05-01 to 2013-10-31 | 45,000 | USD | 184 |
Amortization of intangible assets
Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-08-01 to 2014-10-31 | 17,000 | USD | 92 |
| 2014-05-01 to 2014-10-31 | 34,000 | USD | 184 |
| 2013-08-01 to 2013-10-31 | 15,000 | USD | 92 |
| 2013-05-01 to 2013-10-31 | 30,000 | USD | 184 |
Other nonoperating income or expense
Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-08-01 to 2014-10-31 | 88,291 | USD | 92 |
| 2014-05-01 to 2014-10-31 | 379,512 | USD | 184 |
| 2013-08-01 to 2013-10-31 | -367 | USD | 92 |
| 2013-05-01 to 2013-10-31 | -227 | USD | 184 |
Change in inventories
The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-05-01 to 2014-10-31 | 0 | USD | 184 |
| 2013-05-01 to 2013-10-31 | 1,219 | USD | 184 |
Inspect the source
- Entity
- TENAX THERAPEUTICS, INC. / CIK 0000034956
- Captured
- 2026-09-19T14:46:45.117Z
- SEC response SHA-256
3f4f90f5f823d316ffb20bc63506ae090888657f5ff1cb9568439e153f028cf5
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0000034956.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))